Form 4: Shattuck Labs Director Helen M. Boudreau Granted Stock Options

Director Helen M. Boudreau of Shattuck Labs, Inc. was granted stock options to purchase 27,700 shares of common stock on June 21, 2024.

Summary

• Helen M. Boudreau, a director of Shattuck Labs, Inc., was granted stock options on June 21, 2024.
• The options allow her to purchase 27,700 shares of Shattuck Labs' common stock at an exercise price of $4.37 per share.
• The options vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to continued service to the Issuer.
• The options expire on June 21, 2034.

Sentiment

Score: 7

Explanation: The document reflects a standard corporate action (granting of stock options) which is generally viewed neutrally to positively as it incentivizes management. The sentiment is therefore moderately positive.

Positives

• The granting of stock options to a director aligns her interests with those of the shareholders.
• The vesting schedule incentivizes continued service to the company.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting and expiration dates of the options.

Industry Context

Stock options are a common form of executive compensation in the biotechnology industry, used to attract and retain talent and align their interests with those of shareholders.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for directors and executives in publicly traded companies, particularly in the biotech sector.
• The vesting schedule of one year or prior to the next annual meeting is fairly typical.
• Companies like Amgen, Gilead, and Biogen also utilize stock options as part of their executive compensation plans.

Stakeholder Impact

• Shareholders may view the granting of stock options positively as it aligns the director's interests with theirs.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates